| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aquestive Therapeutics Inc (NASDAQ: AQST)
AQST Technical Analysis
2
| As on 9th Jun 2023 AQST STOCK Price closed @ 2.12 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.79 & Strong Sell for SHORT-TERM with Stoploss of 3.31 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AQSTSTOCK Price
| Open | 2.15 | Change | Price | % |
| High | 2.21 | 1 Day | -0.03 | -1.40 |
| Low | 2.07 | 1 Week | -0.12 | -5.36 |
| Close | 2.12 | 1 Month | 0.84 | 65.62 |
| Volume | 441881 | 1 Year | -3.58 | -62.81 |
| 52 Week High 6.22 | 52 Week Low 0.63 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| AQST Daily Charts |
AQST Intraday Charts |
Whats New @ Bazaartrend |
AQST Free Analysis |
|
|
AQST Important Levels Intraday
| RESISTANCE | 2.39 |
| RESISTANCE | 2.30 |
| RESISTANCE | 2.25 |
| RESISTANCE | 2.20 |
| SUPPORT | 2.04 |
| SUPPORT | 1.99 |
| SUPPORT | 1.94 |
| SUPPORT | 1.85 |
AQST Forecast May 2024
| 4th UP Forecast | 5.55 |
| 3rd UP Forecast | 4.45 |
| 2nd UP Forecast | 3.77 |
| 1st UP Forecast | 3.09 |
| 1st DOWN Forecast | 1.15 |
| 2nd DOWN Forecast | 0.47 |
| 3rd DOWN Forecast | -0.21 |
| 4th DOWN Forecast | -1.31 |
AQST Weekly Forecast
| 4th UP Forecast | 3.30 |
| 3rd UP Forecast | 2.92 |
| 2nd UP Forecast | 2.69 |
| 1st UP Forecast | 2.45 |
| 1st DOWN Forecast | 1.79 |
| 2nd DOWN Forecast | 1.55 |
| 3rd DOWN Forecast | 1.32 |
| 4th DOWN Forecast | 0.94 |
AQST Forecast2024
| 4th UP Forecast | 12.97 |
| 3rd UP Forecast | 9.49 |
| 2nd UP Forecast | 7.34 |
| 1st UP Forecast | 5.19 |
| 1st DOWN Forecast | -0.95 |
| 2nd DOWN Forecast | -3.1 |
| 3rd DOWN Forecast | -5.25 |
| 4th DOWN Forecast | -8.73 |
Aquestive Therapeutics Inc ( NASDAQ USA Symbol : AQST )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AQST Business Profile
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; and Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation of epinephrine for the treatment of anaphylaxis; and AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey. Address: 30 Technology Drive, Warren, NJ, United States, 07059
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service